21 CFR 866, Subpart G - Tumor Associated Antigen immunological Test Systems
- § 866.6010 — Tumor-associated antigen immunological test system.
- § 866.6020 — Immunomagnetic circulating cancer cell selection and enumeration system.
- § 866.6030 — AFP-L3% immunological test system.
- § 866.6040 — Gene expression profiling test system for breast cancer prognosis.
- § 866.6050 — Ovarian adnexal mass assessment score test system.
Title 21 published on 2012-04-01
The following are only the Rules published in the Federal Register after the published date of Title 21.
For a complete list of all Rules, Proposed Rules, and Notices view the Rulemaking tab.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
Title 21 published on 2012-04-01
The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR 866 after this date.
